Guselkumab, an anti-interleukin-23 monoclonal antibody, for the treatment of moderate to severe plaque-type psoriasis in Japanese patients: Efficacy and safety results from a phase 3, randomized, double-blind, placebo-controlled study
| Image |  |
|---|---|
| Description | scientific article published on 15 June 2018 |
| Author/s |
author: Hiroshi Kubo Hitomi Morishima |
| Publication date | June 15, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |